Ten compounds with binding free energy less than or equal to −5 Kcal/mol with reference to synthetic drugs FE-15, RK33 and NZ-51 and strong hydrogen bond interactions as similar to crystallized DDX3 protein (2I4I) were further considered for anti-cancer activity. The gene discussed is DDX3X; the disease is cancer.